Ranbaxy launches ABSORICA in the US
Ranbaxy Laboratories has launched ABSORICA (isotretinoin) 25 mg and 35 mg capsules into the US healthcare market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Strides Arcolab ties up with Shasun Pharmaceuticals
Creates vertically integrated pharma company with multiple revenue streams
Decreasing herb production could hamper Ayurveda industry
Shortages, fears of dilution could prevent industry tapping increasing demand
Cipla to set up a manufacturing unit in Iran
To invest about $36.65 million over three years on areas including machinery and equipment for the facility
Novartis announces change in Executive Committee
Novartis confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (Lilly) in…
Strides Arcolab, GMS Holdings agreement
Announces strategic investor for its greenfield biotech project
Merck Serono to collaborate with The Institute of Cancer Research, London and Wellcome Trust
To co-develop anti-cancer drugs
Sun Pharma and Merck in agreement
Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront…
‘Quality is a philosophy regardless of geographies’
Dr Alexandra Pearce, Senior Vice President and Head Global Regulatory Affairs - Glenmark Pharmaceuticals, talks about the…